LoadingLoadingLoading37 funds hold it.Insiders net selling.
Net selling: insiders sold $9.6M and bought $79K on the open market in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 21, 2026
Financial period
Q3 2026
Earnings per share
$2.99 expected
Estimates as of Nov 3, 2026
EPS expected
$2.92 to $3.28
Revenue expected
10 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 21, 2026 | $3.02est. $2.99 | +1.02%beat | $1.74BSEC filing | +13.0%from $1.54B |
| Jun 30, 2026Reported Jul 22, 2026 | $2.99est. $2.91 | +2.75%beat | $1.71BCompany release | +0.8%from $1.69B |
| Mar 31, 2026Reported Apr 22, 2026 | $3.36est. $3.37 | -0.25%in line | $1.88BSEC filing | +14.5%from $1.64B |
| Dec 31, 2025Reported Feb 4, 2026 | $2.77est. $2.74 | +0.99%in line | $1.65BAlpha Vantage | +8.1%from $1.53B |
| Sep 30, 2025Reported Oct 22, 2025 | $2.68est. $2.63 | +1.90%beat | $1.54BSEC filing | -3.0%from $1.58B |
| Jun 30, 2025Reported Jul 23, 2025 | $2.96est. $2.92 | +1.37%beat | $1.69BSEC filing | +10.4%from $1.53B |
| Mar 31, 2025Reported Apr 23, 2025 | $2.80est. $2.81 | -0.36%in line | $1.64BSEC filing | +10.4%from $1.49B |
| Dec 31, 2024Reported Feb 12, 2025 | $2.52est. $2.45 | +3.05%beat | $1.53BAlpha Vantage | +6.0%from $1.44B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.65B | $1.88B | $1.71B | $1.74B |
| Cost of what it sold | $241.1M | $223.0M | $524.7M | $104.2M |
| Gross profit | $1.41B | $1.66B | $1.18B | $1.63B |
| What it spent | ||||
| Sales and admin | $47.9M | $28.2M | $29.1M | $346.3M |
| Other operating costs | $340.1M | $319.2M | $45.3M | $145.4M |
| Total operating expenses | $388.0M | $347.4M | $74.4M | $491.7M |
| What was left | ||||
| Operating profit | $1.02B | $1.31B | $1.11B | $1.14B |
| Interest on debt | $43.7M | $43.6M | $43.6M | $43.5M |
| Profit before tax | $1.58B | $1.51B | $1.33B | $1.35B |
| Tax | $410.4M | $356.6M | $285.9M | $317.9M |
| Net profit | $1.17B | $1.15B | $1.04B | $1.04B |
| EBITDA | $1.65B | $1.64B | $946.5M | $2.40B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is mixed
Cboe Joins Capital Markets Alliance Challenge to CFTC Approval of Single-Stock Perpetual Derivatives
NeutralNov 3Cboe Global Markets (CBOE) Could Be 44% Overvalued After Earnings And SPX Deal
NeutralNov 3Hyperliquid Founder on US Expansion: "Compliance by Individual Operators, Not Exchange Licensing"
NeutralNov 3Form 4 CME Group Inc Class A: Julie Winkler (Sr MD Chief Commercial Officer) For: 2 November
NeutralNov 3CME Group sr md Julie Winkler sells $3.08M in common stock By Investing.com
Leans bearishNov 3CME Group sr md Julie Winkler sells $3.08M in common stock
NeutralNov 3CME Group sr md Julie Winkler sells $3.08M in common stock
NeutralNov 3Form 4 CME Group Inc Class A: Julie Winkler (Sr MD Chief Commercial Officer) For: 2 November
NeutralNov 3
